As of August 29, 2026, ARS Pharmaceuticals's top three insider holders are James E Flynn (TenPercentOwner, 9.77Mn shares), James E Flynn (TenPercentOwner, 9.77Mn shares), Sarina Tanimoto (Chief Medical Officer, 7.97Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | James E Flynn | TenPercentOwner | 0 | 9,774,508 | 9,774,508 | 48.0% | 01 Jul, 2025 |
| 2 | Pratik Shah | Director | 0 | 4,474,554 | 4,474,554 | 22.0% | 14 Nov, 2025 |
| 3 | Rajeev Dadoo | Director | 0 | 3,009,677 | 3,009,677 | 14.8% | 10 Nov, 2022 |
| 4 | Sarina Tanimoto | Chief Medical Officer | 0 | 1,247,447 | 1,247,447 | 6.1% | 21 Aug, 2025 |
| 5 | Richard E Lowenthal | President And Ceo | 0 | 1,196,494 | 1,196,494 | 5.9% | 22 Aug, 2025 |
| 6 | Laura Shawver | Chief Executive Officer | 210,346 | 0 | 210,346 | 1.0% | 08 Apr, 2025 |
| 7 | Alexander A Fitzpatrick | Chief Legal Officer | 90,910 | 0 | 90,910 | 0.4% | 12 Jun, 2026 |
| 8 | Michael Kelly | Director | 0 | 83,225 | 83,225 | 0.4% | 10 Nov, 2022 |
| 9 | Jonathan Piazza | Chief Financial Officer | 69,225 | 0 | 69,225 | 0.3% | 04 May, 2022 |
| 10 | Valerie Odegard | President And Cso | 61,639 | 0 | 61,639 | 0.3% | 04 May, 2022 |
| 11 | Naomi Hunder | Chief Medical Officer | 54,427 | 0 | 54,427 | 0.3% | 04 May, 2022 |
| 12 | Russ Hawkinson | Sr. Vice President Of Finance | 37,251 | 0 | 37,251 | 0.2% | 04 May, 2022 |
| 13 | Eric Karas | Chief Commercial Officer | 12,176 | 0 | 12,176 | 0.1% | 12 Jun, 2026 |
| 14 | Brian Dorsey | Chief Operating Officer | 10,789 | 0 | 10,789 | 0.1% | 14 Nov, 2025 |
| 15 | Kathleen D. Scott | Chief Financial Officer | 10,042 | 0 | 10,042 | 0.0% | 22 Aug, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 01 Jul, 2026 | Donn Casale | President | Acquired A | 898,456 | $0.00 | $0 | 898,456 | Direct |
| 24 Jun, 2026 | Michael Kelly | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 24 Jun, 2026 | Peter A. Thompson | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 24 Jun, 2026 | Rajeev Dadoo | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 24 Jun, 2026 | Saqib Islam | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 24 Jun, 2026 | Brent L Saunders | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 24 Jun, 2026 | Laura Shawver | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 24 Jun, 2026 | Pratik Shah | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 24 Jun, 2026 | Capital Management, L.P. Ra | Director, TenPercentOwner | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Indirect |
| 24 Jun, 2026 | Phillip M Schneider | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 12 Jun, 2026 | Eric Karas | Chief Commercial Officer | Acquired M | 25,000 | $1.50 | $37.50K | 37,176 | Direct |
| 12 Jun, 2026 | Alexander A Fitzpatrick | Chief Legal Officer | Disposed S | 3,355 | $10.00 | $33.55K | 90,910 | Direct |
| 12 Jun, 2026 | Eric Karas | Chief Commercial Officer | Disposed S | 25,000 | $10.00 | $250.00K | 12,176 | Direct |
| 12 Jun, 2026 | Eric Karas | Chief Commercial Officer | Disposed M | 25,000 | $0.00 | $0 | 519,588 | Direct |
| 02 Jan, 2026 | Justin Chakma | Chief Business Officer | Acquired A | 240,000 | $0.00 | $0 | 240,000 | Direct |
| 02 Jan, 2026 | Alexander A Fitzpatrick | Chief Legal Officer | Acquired A | 240,000 | $0.00 | $0 | 240,000 | Direct |
| 02 Jan, 2026 | Richard E Lowenthal | President And Ceo | Acquired A | 875,000 | $0.00 | $0 | 875,000 | Direct |
| 02 Jan, 2026 | Richard E Lowenthal | President And Ceo | Acquired A | 875,000 | $0.00 | $0 | 875,000 | Direct |
| 02 Jan, 2026 | Sarina Tanimoto | Chief Medical Officer | Acquired A | 240,000 | $0.00 | $0 | 240,000 | Direct |
| 02 Jan, 2026 | Sarina Tanimoto | Chief Medical Officer | Acquired A | 240,000 | $0.00 | $0 | 240,000 | Direct |